Respiratory-syncytial virus immunoprophylaxis on asthma symptoms development in prematurity with bronchopulmonary dysplasia

Respiratory-syncytial virus immunoprophylaxis on asthma symptoms development in prematurity with bronchopulmonary dysplasia

Background: Infants with respiratory-syncytial virus bronchiolitis hospitalization are more likely to develop wheezing and subsequent asthma. Reportedly, palivizumab prophylaxis effectively prevents respiratory-syncytial virus hospitalization in high-risk children—such as premature infants or infant...

Full description

Bibliographic Details
Main Authors:	Li-Ching Fang, MD, Jen-Yu Wang, MD, Hsin-Hui Yu, MD, PhD, Li-Chieh Wang, MD, PhD, Bor-Luen Chiang, MD, PhD
Format:	Article
Language:	English
Published:	Elsevier 2023-11-01
Series:	Journal of Allergy and Clinical Immunology: Global
Subjects:	Asthma palivizumab RSV bronchiolitis bronchopulmonary dysplasia prematurity
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772829323000863

Similar Items

Correlation of retinopathy of prematurity with bronchopulmonary dysplasia
by: Podraza Wojciech, et al.
Published: (2018-03-01)

Patient equity and respiratory syncytial virus Immunoprophylaxis
by: H. Cody Meissner
Published: (2019-01-01)

Safety of sildenafil in premature infants at risk of bronchopulmonary dysplasia: Rationale and methods of a phase II randomized trial
by: Jason E. Lang, et al.
Published: (2022-12-01)

Effectiveness of palivizumab immunoprophylaxis in preterm infants against respiratory syncytial virus disease in Qatar
by: Abushahin A, et al.
Published: (2018-01-01)

An Innovative Model of Bronchopulmonary Dysplasia in Premature Infants
by: Xiaoyue Zhang, et al.
Published: (2020-05-01)

Early prediction of moderate to severe bronchopulmonary dysplasia in extremely premature infants
by: Amit Sharma, et al.
Published: (2020-06-01)

The relationship between eosinophilia and bronchopulmonary dysplasia in premature infants at less than 34 weeks' gestation
by: Joo Yun Yang, et al.
Published: (2014-04-01)

Airway malacia in premature infant twins with bronchopulmonary dysplasia: Two case reports
by: Wanwan Yang, et al.
Published: (2022-01-01)

PREDICTIVE CAPABILITY OF NEUROTRACTOGRAPHY IN PREMATURE NEWBORNS WITH LOW AND EXTREMELY LOW BODY WEIGHT WITH MANIFESTING BRONCHOPULMONARY DYSPLASIA
by: M. P. Yakovenko, et al.
Published: (2017-10-01)

Treatment and prophylaxis of moderate and severe bronchopulmonary dysplasia in premature neonates
by: A.V. Bolonska, et al.
Published: (2021-09-01)

Bronchopulmonary Dysplasia in Extremely Premature Infants: A Scoping Review for Identifying Risk Factors
by: Masato Ito, et al.
Published: (2023-02-01)

Neonatal hematological parameters and the risk of moderate-severe bronchopulmonary dysplasia in extremely premature infants
by: Xueyu Chen, et al.
Published: (2019-04-01)

A Pathogenic Relationship of Bronchopulmonary Dysplasia and Retinopathy of Prematurity? A Review of Angiogenic Mediators in Both Diseases
by: Ashley Stark, et al.
Published: (2018-06-01)

Where are we now with the role of steroids in the management of bronchopulmonary dysplasia (BPD) in extremely premature babies?
by: MATTHEW HURLEY, et al.
Published: (2016-08-01)

Prevention of bronchiolitis from the hospital to home: enviromental and pharmacological strategies
by: Andrea Dotta
Published: (2015-10-01)

A nomogram for predicting the risk of Bronchopulmonary dysplasia in premature infants
by: Xian Shen, et al.
Published: (2023-08-01)

Response of Very Premature Infants with Bronchopulmonary Dysplasia to Inhaled Salbutamol
by: Ha-Nam Nguyen, et al.
Published: (2020-12-01)

Bronchoconstriction following instillation of phenylephrine eye drops in premature infants with bronchopulmonary dysplasia: two cases report
by: Hyun Jee Kim, et al.
Published: (2015-12-01)

Platelet is the early predictor of bronchopulmonary dysplasia in very premature infants: an observational cohort study
by: Xiaoling Wang, et al.
Published: (2022-03-01)

Risk Factors of Very Severe RSV Infections in a Multicenter Cohort of Very Preterm and Extreme Preterm Babies Receiving or Not Palivizumab
by: Gwenaelle Mulot, et al.
Published: (2022-07-01)

Bronchopulmonary Dysplasia: An Overview
by: Gisondo CM, et al.
Published: (2020-09-01)

Bronchopulmonary dysplasia frequency and risk factors in very low birth weight infants: A 3-year retrospective study
by: Turgay Cokyaman, et al.
Published: (2020-03-01)

Cognitive performance of premature infants: association between bronchopulmonary dysplasia and cognitive skills. Cross-sectional study
by: Rosane Reis de Mello, et al.
Published: (2017-07-01)

Biomarker Potential of the Soluble Receptor for Advanced Glycation End Products to Predict Bronchopulmonary Dysplasia in Premature Newborns
by: Hayato Go, et al.
Published: (2021-04-01)

Bronchopulmonary dysplasia: an old and new disease
by: Caterina Franco, et al.
Published: (2014-10-01)

Product review on the monoclonal antibody palivizumab for prevention of respiratory syncytial virus infection
by: Bernhard Resch
Published: (2017-09-01)

Inhaled nitric oxide in premature infants for preventing bronchopulmonary dysplasia: a meta-analysis
by: Yi Zheng, et al.
Published: (2023-03-01)

Development of a blood proteins-based model for bronchopulmonary dysplasia prediction in premature infants
by: Wanting Ou, et al.
Published: (2023-06-01)

Review of the Safety, Efficacy and Tolerability of Palivizumab in the Prevention of Severe Respiratory Syncytial Virus (RSV) Disease
by: O'Hagan S, et al.
Published: (2023-09-01)

Racial disparities in calculated risk for bronchopulmonary dysplasia: a dataset
by: Zachary A. Vesoulis, et al.
Published: (2020-06-01)

Comparative two time-point proteome analysis of the plasma from preterm infants with and without bronchopulmonary dysplasia
by: Magdalena Zasada, et al.
Published: (2019-08-01)

A modified lung ultrasound score to evaluate short-term clinical outcomes of bronchopulmonary dysplasia
by: Ying-Hua Sun, et al.
Published: (2022-03-01)

Update on respiratory syncytial virus hospitalizations among U.S. preterm and term infants before and after the 2014 American Academy of Pediatrics policy on immunoprophylaxis: 2011-2017
by: Jaime Fergie, et al.
Published: (2021-05-01)

Risk Identification of Bronchopulmonary Dysplasia in Premature Infants Based on Machine Learning
by: Jintao Lei, et al.
Published: (2021-08-01)

Respiratory support strategies in the prevention and treatment of bronchopulmonary dysplasia
by: Erik B. Hysinger, et al.
Published: (2023-03-01)

Influence of time under mechanical ventilation on bronchopulmonary dysplasia severity in extremely preterm infants: a pilot study
by: Victoria Escobar, et al.
Published: (2020-05-01)

Cost-utility analysis of palivizumab for preventing respiratory syncytial virus in preterm neonates and infants in Colombia
by: Jaime E. Ordóñez, et al.
Published: (2024-04-01)

Time-resolved transcriptomic profiling of the developing rabbit’s lungs: impact of premature birth and implications for modelling bronchopulmonary dysplasia
by: Matteo Storti, et al.
Published: (2023-03-01)

Criteria for the duration of anti-inflammatory therapy in children with bronchopulmonary dysplasia
by: Т. І. Stepanenko, et al.
Published: (2019-04-01)

Evaluation of mediators of fibrosis and angiogenesis in the blood serum of premature infants with bronchopulmonary dysplasia
by: E. L. Semikina, et al.
Published: (2023-06-01)